{"id":10793,"date":"2018-06-28T05:00:10","date_gmt":"2018-06-28T09:00:10","guid":{"rendered":"https:\/\/medicarereport.org\/?p=10793"},"modified":"2018-06-27T16:26:12","modified_gmt":"2018-06-27T20:26:12","slug":"mass-gets-a-thumbs-down-on-negotiating-medicaid-prices-but-oklahoma-wins-on-value-rebates","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=10793","title":{"rendered":"Mass. gets a thumbs-down on negotiating Medicaid prices, but Oklahoma wins on \u2018value\u2019 rebates"},"content":{"rendered":"<p>(By Erin Mershon for ST<em>A<\/em>T)<\/p>\n<p class=\"big-cap-wrap danger-zone\"><span class=\"big-cap\">WASHINGTON \u2014 The Trump administration wants states to experiment with drug prices \u2014 but not too much. <a href=\"https:\/\/www.statnews.com\/2018\/06\/27\/mass-medicaid-oklahoma-drugs\/?utm_source=STAT+Newsletters&amp;utm_campaign=5e63835fe6-Pharmalot&amp;utm_medium=email&amp;utm_term=0_8cab1d7961-5e63835fe6-149624405\">Continue reading article here&#8230;<\/a><\/span><\/p>\n<p class=\"big-cap-wrap danger-zone\"><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4372\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png\" alt=\"\" width=\"300\" height=\"32\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p class=\"big-cap-wrap danger-zone\">\n<pre>Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By Erin Mershon for STAT) WASHINGTON \u2014 The Trump administration wants states to experiment with drug prices \u2014 but not<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20,16,15],"tags":[],"class_list":["post-10793","post","type-post","status-publish","format-standard","hentry","category-health-care-redesign","category-medicaid","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/10793","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=10793"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/10793\/revisions"}],"predecessor-version":[{"id":10794,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/10793\/revisions\/10794"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=10793"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=10793"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=10793"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}